Novak & Powell Financial Services’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Novak & Powell Financial Services's AMGN Position: Q2 2026 in Review
Novak & Powell Financial Services reduced its Amgen (AMGN) stake by 5.3% in Q2 2026, selling an estimated $51K and leaving 2,687 shares worth $973K. The position accounts for 0.46% of the portfolio, ranked #48.
Novak & Powell Financial Services first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $998K in Q1 2026. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Novak & Powell Financial Services held 2,687 shares of Amgen worth $973K as of Q2 2026.
- Novak & Powell Financial Services sold 149 Amgen shares in Q2 2026, an estimated $51K.
- Amgen made up 0.46% of Novak & Powell Financial Services's portfolio in Q2 2026, its #48 holding.
- Novak & Powell Financial Services first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- Novak & Powell Financial Services's Amgen position peaked at $998K in Q1 2026.
- 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Novak & Powell Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.